Understanding PMOS: The New Terminology for PCOS
Polyendocrine metabolic ovarian syndrome (PMOS) redefines the understanding of a common endocrine disorder previously known as PCOS.
PMOS affects 10%-13% of women of childbearing age, highlighting its prevalence.
Lifestyle changes and psychological support are crucial in managing PMOS.
Women with PMOS face increased risks for cardiometabolic diseases, necessitating regular health assessments.
The recent rebranding of polycystic ovarian syndrome (PCOS) to polyendocrine metabolic ovarian syndrome (PMOS) marks a significant shift in the medical community's approach to this prevalent endocrine disorder. Announced in May 2026, this change aims to reflect the multifaceted nature of the condition, which encompasses reproductive, cardiometabolic, dermatologic, and mental health aspects. PMOS is now recognized as the most common endocrinopathy among women of reproductive age, affecting approximately 10% to 13% of this demographic.
Historically, PCOS was often viewed narrowly as a gynecological issue, but the new nomenclature emphasizes its broader implications. The etiology of PMOS remains unclear, with both genetic and environmental factors contributing to its development. Central to the condition are pathophysiological defects such as elevated androgen production and insulin resistance, which can lead to increased cardiometabolic risks for affected women. Clinicians are encouraged to consider PMOS in women presenting with symptoms of hyperandrogenism, irregular menstrual cycles, or polycystic ovarian morphology identified through imaging.
Diagnosis of PMOS involves a comprehensive evaluation, including hormonal assessments and consideration of additional factors such as family history and obesity. Key diagnostic tests may include measuring levels of luteinizing hormone, testosterone, and anti-Müllerian hormone, among others. If elevated testosterone levels are detected, urgent referrals may be warranted to rule out androgen-secreting tumors. Management strategies focus on lifestyle interventions, emphasizing the importance of weight loss and exercise to mitigate metabolic and psychological challenges associated with PMOS.
The implications of PMOS extend beyond reproductive health, as women with this syndrome face heightened risks for cardiovascular diseases, including myocardial infarction and stroke. Regular monitoring of cardiometabolic risk factors is essential, with recommendations for annual assessments regardless of age or weight. This proactive approach aims to educate women about their increased risk for developing serious health conditions and the importance of maintaining a healthy lifestyle.
Looking ahead, healthcare providers must prioritize the identification and management of PMOS in clinical practice. This includes educating patients about the condition, its risks, and effective management strategies. As awareness grows, the hope is that women with PMOS will receive the comprehensive care they need to improve their overall health outcomes and quality of life.
